Status:
COMPLETED
School Health Implementation Network: Eastern Mediterranean
Lead Sponsor:
Human Development Research Foundation, Pakistan
Collaborating Sponsors:
University of Liverpool
University of Washington
Conditions:
Behavioral Symptoms
Behavioral Problem
Eligibility:
All Genders
8-13 years
Phase:
NA
Brief Summary
Background An estimated 10-20% of children globally are affected by a mental health problem. Child mental health has been identified as a priority issue by the World Health Organization's Eastern Med...
Eligibility Criteria
Inclusion
- Eligibility Criteria for Children
- Inclusion criteria for children:
- Children meeting the following criteria will be included in the study; i. Aged 8-13 years living with parents/primary caregivers ii. Written parent/primary caregiver informed consent or witnessed consent (in case the parent is unable to read and write, the informed consent will be obtained from both parent and witness) and child assent for participation in the study.
- iii. Screen positive on teacher-rated SDQ (total difficulties score \> 12) and parent-rated SDQ (total difficulties score ≥ 14).
- Exclusion criteria for children:
- i. Children at high risk of abuse or harm to self or others as reported by the students themselves, teachers or parents/primary caregivers, or identified by the trained assessment team during screening.
- ii. Children who require immediate or on-going in-patient medical or psychiatric care, as reported by student themselves or teachers or parents/primary caregivers or identified by the trained assessment team during screening.
- iii. Children with deafness, blindness and speech difficulties or with developmental disorders as defined by the WHO mhGAP intervention guide identified by the trained assessment team during screening.
- Exclusion from the evaluation will not impact the care received by the school children as all children studying in public schools will receive intervention as part of routine implementation of WHO SMHP.
Exclusion
Key Trial Info
Start Date :
October 7 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 22 2022
Estimated Enrollment :
971 Patients enrolled
Trial Details
Trial ID
NCT04091633
Start Date
October 7 2019
End Date
April 22 2022
Last Update
August 3 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Human Development Research Foundation
Islamabad, Pakistan